P. Mandall

Five‐year outcomes after iodine‐125 seed brachytherapy for low‐risk prostate cancer at three cancer centres in the UK

P. Hoskin, J. Logue, D. Bottomley, 2014, BJU international.

Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapy.

P. Hoskin, J. Logue, D. Bottomley, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patient-reported outcomes and health-related quality of life in prostate cancer treated with a single fraction of high dose rate brachytherapy combined with hypofractionated external beam radiotherapy.

J. Logue, C. Taylor, T. Elliott, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy.

J. Logue, C. West, J. Livsey, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Report on the early efficacy and tolerability of I(125) permanent prostate brachytherapy from a UK multi-institutional database.

D. Ash, D. Bottomley, J. Logue, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).